As of 2024-12-15, the Relative Valuation of Bright Minds Biosciences Inc (DRUG.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 53.27 CAD, the upside of Bright Minds Biosciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-12-11 | -104.08 |
| 2024-12-10 | -104.19 |
| 2024-12-09 | -106.05 |
| 2024-12-06 | -107.30 |
| 2024-12-05 | -104.54 |
| 2024-12-04 | -127.54 |
| 2024-12-03 | -127.15 |
| 2024-12-02 | -131.80 |
| 2024-11-29 | -119.59 |
| 2024-11-27 | -105.62 |
| 2024-11-26 | -110.02 |
| 2024-11-25 | -103.02 |
| 2024-11-22 | -96.51 |
| 2024-11-21 | -88.27 |
| 2024-11-20 | -91.81 |
| 2024-11-19 | -102.20 |
| 2024-11-18 | -100.13 |
| 2024-11-15 | -109.64 |
| 2024-11-14 | -117.63 |
| 2024-11-13 | -115.27 |
| 2024-11-12 | -110.00 |
| 2024-11-11 | -119.88 |
| 2024-11-08 | -127.72 |
| 2024-11-07 | -131.04 |
| 2024-11-06 | -149.89 |
| 2024-11-05 | -146.35 |
| 2024-11-04 | -135.61 |
| 2024-11-01 | -131.19 |
| 2024-10-31 | -132.23 |
| 2024-10-30 | -130.37 |
| 2024-10-29 | -123.83 |
| 2024-10-28 | -131.21 |
| 2024-10-25 | -131.88 |
| 2024-10-24 | -133.64 |
| 2024-10-23 | -125.45 |
| 2024-10-22 | -125.92 |
| 2024-10-21 | -131.88 |
| 2024-10-18 | -200.69 |
| 2024-10-17 | -58.61 |
| 2024-10-16 | -76.76 |
| 2024-10-15 | -86.18 |
| 2024-10-08 | -3.20 |
| 2024-10-03 | -3.13 |
| 2024-10-02 | -2.75 |